Molecular markers for cancer prognosis and treatment: Have we struck gold?
Authors:
- Khaled AzizKAKhaled Aziz
- Mihalis I. PanayiotidisMihalis I. Panayiotidis
- Alexandros G. GeorgakilasAlexandros G. Georgakilas
- 1 December 2012
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 327 (1-2) , 142-152
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- Expression of Endoplasmic Reticulum Stress Proteins Is a Candidate Marker of Brain Metastasis in both ErbB-2+ and ErbB-2− Primary Breast TumorsThe American Journal of Pathology, 2011
- Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technologyBreast Cancer Research and Treatment, 2011
- CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3Cancer Cell, 2011
- Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancerCancer, 2011
- Correlation of Cellular Immunity With Human Papillomavirus 16 Status and Outcome in Patients With Advanced Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2010
- CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the Breast Cancer Family RegistryCancer, 2010
- Integrating Epidermal Growth Factor Receptor Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head-and-Neck Squamous Cell CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Proteomics technologies for the global identification and quantification of proteins2010
- Prognostic significance of ataxia‐telangiectasia mutated, DNA‐dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86‐kD subunit expression in patients with nonsmall cell lung cancerCancer, 2008
- Response to Therapy and Outcomes in Oropharyngeal Cancer Are Associated With Biomarkers Including Human Papillomavirus, Epidermal Growth Factor Receptor, Gender, and SmokingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007